Credit CDC
#15,688
Nine days ago, in Colorado Governor Statement On The 1st Detection Of The COVID B.1.1.7 Variant In U.S., we saw the first official confirmation of what was pretty much a foregone conclusion; the B.1.1.7 COVID variant now ravaging the UK was already in the United States.
The reality of life in this highly mobile 21st century is that disease threats that once were local, can now spread globally in a matter of hours or days. Vast oceans and prolonged travel times no longer protect us against infected travelers crossing borders.International travel, even when greatly subdued as it is by the current pandemic, is a highly efficient way to spread viruses (see my 2009 blog How The Next Pandemic Will Arrive).
Border closings and travel bans - if implement early enough - may help slow the spread of an infectious disease, but given porous borders and asymptomatic carriers, are unlikely to work for very long.
California 26
Florida 22
Colorado 2
New York 1
Georgia 1
*The cases identified above are based on a sampling of SARS-CoV-2-positive specimens and do not represent the total number of B.1.1.7 lineage cases that may be circulating in the United States and may not match numbers reported by states, territories, tribes, and local officials.
†Numbers will be updated on Tuesdays and Thursdays by noon.
Assuming early reports (see MRC Report #42: Transmission of SARS-CoV-2 Lineage B.1.1.7 in England) are reasonably accurate, we can expect the number of B.1.1.7 variant cases to steadily rise here in the weeks and months to come, with it eventually becoming the dominant strain.
Unless, of course, another - even more transmissible variant - should arise somewhere in the world.
The good news is, so far there is no evidence this B.1.1.7 variant produces more severe illness, or that it will evade the vaccine. But even so, unless we work to reduce its spread, its increased transmissibility poses a significant threat of overwhelming our healthcare delivery systems.